Clinical Trials Logo

Clinical Trial Summary

The purpose of this research study is to assess the long term safety of Dysport® in hemiparetic subjects with lower limb spasticity due to stroke or traumatic brain injury over repeated treatment cycles.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01251367
Study type Interventional
Source Ipsen
Contact
Status Completed
Phase Phase 3
Start date June 2011
Completion date April 2015

See also
  Status Clinical Trial Phase
Completed NCT06381999 - Validity and Inter-rater Reliability for Early Recognition of Spasticity Using the Decision Tree Tool
Completed NCT00460564 - Study Of GSK1358820 In Patients With Post-Stroke Upper Limb Spasticity Phase 3
Completed NCT00460655 - Study of GSK1358820 In Patients With Post-Stroke Lower Limb Spasticity Phase 3
Completed NCT03251521 - Pain During Injection With Botulinum Toxin in Post-stroke Spasticity Treatment N/A